Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12
WO2005072766A2
Peptides that bind to hsp90 proteins
KR20050084921A
INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES
HK1038886A1
Use of alpha1beta1 integrin receptor inhibitors and tgf-beta1 inhibitors for the preparation of a pharmaceutical composition for treatment of kidney disorder.
IL139687A
Use of ??1??1 integrin receptor inhibitors and tgf-??1 inhibitors for the preparation of pharmaceutical compositions for the treatment of kidney disease
BR9911067A
Use of alpha1beta1 integrin receptor inhibitors and tgf-beta1 inhibitors in the treatment of kidney disease
WO9961040A2
USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE
IL139687D0
USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE
US6492325B1
Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
EP1042726A1
System and method for acoustic response measurement in the ear canal
